AIDS Research
Ten Costa Ricans will
partake in the follow-up
studies for a new drug
used to fight AIDS.
These patients developed
resistance to the drugs
currently available to
treat the disease and
they need a new option.
“The study takes place
in 125 countries and it
is designed to obtain
further data on the
effectiveness and safety
of using maraviroc
–marketed under the
brand Selzentry–, said
pharmaceutical giant
Pfizer’s Central
American medical
director, Genaro Cuesta. |
|
